Participations à des congrès et colloques internationaux (65)
  1. 59. Wauthoz, N. (2011). Temozolomide by inhalation for the treatment of lung tumors : Preclinical investigation and development of dry powder formulations for inhalation. Paper session presented at Forum des sciences pharmaceutiques de la société belge des sciences pharmaceutiques (15ème: 13 et 14/05/2011: Spa).
  2. 60. Wauthoz, N., Deleuze, P., Saumet, A., Duret, C., & Amighi, K. (2010). Development of Temozolomide Dry Powder Formulations for Inhalation for the Treatment of Lung Tumours. Poster présenté à la conférence Journée doctorale pôle santé 2010 (23/12/2010: Campus Erasme).
  3. 61. Wauthoz, N., Deleuze, P., Saumet, A., Duret, C., Kiss, R., & Amighi, K. (2010). Development of Temozolomide Dry Powder Formulations for Inhalation for the Treatment of Lung Tumours. Paper session presented at Journée doctorale ULB/MONS (28/05/2011: Mons).
  4. 62. Lamoral-Theys, D., Dufrasne, F., Wauthoz, N., Kerff, F., Lefranc, F., Neve, J., Dubois, J., & Kiss, R. (2010). New Polyol Vanilloyl Esters with Anti-tumor Effects Throught the Targeting of Kinases Controlling the Actin Cytoskeleton. Paper session presented at Journée des doctorants de Pharmacie (28 mai 2010: ULB).
  5. 63. Wauthoz, N., & Amighi, K. (2010). In vivo assessment of temozolomide delivery systems for inhalation therapy of lung cancer. Paper session presented at 7th World Meeting on Pharmaceutics Biopharmaceutics and Pharmaceutical Technology (8-11 March 2010: La Valletta, Malta).
  6. 64. Wauthoz, N., Deleuze, P., Hecq, J., Roland, I., Saussez, S., Adanja, I., Debeir, O., Decaestecker, C., Mathieu, V., Kiss, R., & Amighi, K. (2009). In vivo assessment of temozolomide delivery systems for inhalation therapy of lung cancer. Paper session presented at Journée doctorale Pôle Santé (17/12/2009: Campus Erasme).
  7. 65. Delporte, C., Van Antwerpen, P., Pilcer, G., Wauthoz, N., Zouaoui Boudjeltia, K., Moguilevsky, N., Amighi, K., Kauffmann, J.-M., & Neve, J. (2008). Liposomes as a model of phospholipid membrane surfaces in the study of the role of myeloperoxidase in atherogenesis. Poster présenté à la conférence 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (Barcelona).
    8.   Brevets (5)
  8. 1. Amighi, K., Wauthoz, N., & Rosiere, R. (2018). Dry powder inhalation formulation and its use for the therapeutic treatment of lungs.
  9. 2. Amighi, K., Wauthoz, N., & Rosiere, R. (2018). Kit for inhaled chemotherapy, and treatment of lung cancer with said kit.
  10. 3. Van Woensel, M., Wauthoz, N., Rosiere, R., Mathieu, V., Kiss, R., Lefranc, F., Steelant, B., Van Gool, S. W., Mathivet, T., Gerhardt, H., Amighi, K., & De Vleeschouwer, S. (2015). Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration: patent application GB1519841.9 - PCT/EP2016/078547 & WO2017/089392A1.
  11. 4. Rosiere, R., Wauthoz, N., Gelbcke, M., & Amighi, K. (2013). Formulations useful in the treatment of proliferative diseases affecting the respiratory tract: European Patent Number EP 13188995.8-1453. PCT/EP2014/072281 & WO2015/055796.
  12. 5. Amighi, K., Sereno, A. S. A., Ronchi, C., Wauthoz, N., & Hernandez, G. (2013). Inhalable particle comprising tiotropium and indacaterol: European Patent Number EP 13382318.7 & WO2015/018800A1.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>